Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University and its colleges today announced a major new scholarship scheme for Black graduate students as part of a programme to transform its graduate population by creating more funding opportunities for under-represented groups.

Student in front of the Radcliffe Camera © Ashley Tsai / Graduate Photography Competition

The Black Academic Futures programme will provide up to 10 new scholarships to Black UK research students starting studies next year.

Further graduate funding opportunities for under-represented groups have been launched by the University and colleges, with targeted scholarships for students in the Humanities and the Faculty of Law, and with other measures being taken to widen participation in programmes within the Mathematical, Physical and Life Sciences Division, as well as  Medical Sciences.

Black UK graduate students are particularly under-represented at Oxford (around 1.5% of all postgraduate students compared with 4% across the UK sector). The Black Academic Futures scholarship programme aims to transform this position by rapidly increasing both applications from and funded places for well-qualified UK Black graduate students, reinforcing the University’s commitment to addressing race equality, and combatting discrimination. The new programme builds on the University’s commitment to increasing the number of promising postgraduate students from under-represented groups at Oxford. This includes the UNIQ+ access programme which provides research internships for prospective students from disadvantaged backgrounds, who may find progressing to postgraduate study challenging for reasons other than their academic ability.

Read the full story on the University of Oxford website

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.